Prolactin, Training, and Exercise: What Athletes and Active Patients Need to Know

What Prolactin Actually Does in the Body

Prolactin is a 199-amino-acid peptide secreted by lactotroph cells of the anterior pituitary under tonic inhibition by hypothalamic dopamine. Most clinicians associate it with lactation. That framing misses roughly half the picture for non-pregnant active adults.

Prolactin receptors appear on immune cells, gonads, adrenal cortex, liver, and skeletal muscle. At physiologic levels, prolactin supports reproductive hormone balance. At supraphysiologic levels, it competes with dopamine signaling and suppresses the GnRH pulse generator, pulling LH and FSH down with it. The clinical result is secondary hypogonadism, with low testosterone in men and anovulation in women, even when the pituitary itself is structurally normal.

The Dopamine-Prolactin Axis

Dopamine travels from the hypothalamus through the tuberoinfundibular pathway and binds D2 receptors on lactotrophs, continuously restraining prolactin release. Anything that reduces dopamine tone, including stress, opioids, antipsychotics, and heavy training loads, allows prolactin to rise. This is why the exercise-prolactin connection is mechanistically coherent rather than incidental.

A 2015 review in the Journal of Clinical Endocrinology and Metabolism confirmed that physical stress activates the hypothalamic-pituitary axis via serotonergic and opioidergic pathways, both of which reduce dopaminergic tone and thereby lift prolactin [1].

Why Reference Ranges Vary by Lab and Population

Most clinical laboratories report a prolactin upper limit of 18 to 25 ng/mL for men and 25 to 30 ng/mL for women outside pregnancy. These ranges were calibrated on sedentary populations drawn primarily from outpatient clinics. A person who trains twice daily may have a resting prolactin of 20 ng/mL that is entirely benign, while a sedentary person at the same level may have a microadenoma. Context is everything.

The Endocrine Society's 2011 Clinical Practice Guideline on hyperprolactinemia defines pathologic hyperprolactinemia as a consistently elevated level confirmed on at least two fasting, non-exercise-adjacent draws [2].

How Acute Exercise Changes Prolactin

Single bouts of vigorous exercise reliably raise prolactin. The magnitude depends on exercise modality, intensity, and duration.

Intensity Is the Main Driver

A controlled study by Luger and colleagues (published in Journal of Clinical Endocrinology and Metabolism, N=8 trained men) found that running at 80% VO2max produced a mean prolactin rise from 8.2 ng/mL to 18.6 ng/mL, a 127% increase, while the same subjects running at 50% VO2max showed no significant change [3]. Low-to-moderate intensity exercise, roughly below 60% VO2max, generally does not produce a meaningful prolactin spike.

Modality Matters

Resistance training triggers prolactin release differently than endurance work. A 2008 study in the European Journal of Applied Physiology (N=10 recreationally trained men) compared a high-volume squat protocol with a low-volume protocol and found the high-volume condition produced prolactin levels averaging 23.1 ng/mL at 15 minutes post-exercise versus 9.4 ng/mL at rest, P<0.01 [4]. The low-volume protocol produced no significant change.

Marathon-level endurance work produces the most pronounced and prolonged spikes. Prolactin values of 30 to 50 ng/mL have been recorded immediately after marathon completion, levels that, if seen on a routine draw, would trigger a workup for adenoma [5].

Return to Baseline

The spike is transient. In most studies, prolactin returns to within 20% of resting values within 30 to 60 minutes after exercise cessation. This is clinically relevant for blood draw timing. Labs drawn within 60 minutes of a workout produce artifactually elevated prolactin in a meaningful percentage of patients, potentially sending them down an unnecessary MRI pathway.

Practical rule: draw prolactin at least 90 minutes after the last exercise bout, ideally after an overnight fast.

Chronic Training Load and Long-Term Prolactin Patterns

The acute spike story is well-characterized. The chronic story is more nuanced and clinically more important for athletes on hormone therapy or undergoing fertility evaluation.

The Trained Athlete's Blunted Response

Cross-sectional data consistently show that highly trained endurance athletes have lower resting prolactin and a blunted acute prolactin response to a standardized exercise challenge compared with sedentary controls. A study in Medicine and Science in Sports and Exercise (N=22 endurance athletes vs. 20 sedentary controls) reported mean resting prolactin of 6.1 ng/mL in athletes versus 9.8 ng/mL in controls, and the athletes' peak post-exercise values were proportionally lower as well [6]. The proposed mechanism is enhanced dopaminergic tone from regular training, essentially calibrating the hypothalamic inhibitory set-point downward.

Overtraining Syndrome Flips the Pattern

Overtraining syndrome reverses this adaptation. When training volume exceeds recovery capacity for weeks to months, hypothalamic dysfunction emerges. The dopaminergic system becomes blunted, and resting prolactin rises. This is one of several hormonal markers used in overtraining assessment alongside low resting LH, low testosterone, elevated cortisol, and suppressed IGF-1.

The 2013 European College of Sport Science / American College of Sports Medicine joint consensus statement on overtraining syndrome listed elevated resting prolactin as a supportive (though not diagnostic on its own) biomarker of hypothalamic fatigue [7].

Relative Energy Deficiency in Sport

Female athletes and male athletes in lean sports face an additional variable. Relative Energy Deficiency in Sport (RED-S, formerly the "female athlete triad") produces hypothalamic suppression through caloric restriction. Prolactin patterns in RED-S are variable and not as consistently elevated as in overtraining, but the GnRH suppression that results produces the same downstream effect: low LH, low FSH, low sex steroids. Practitioners should interpret prolactin in the context of total energy availability, not in isolation.

Prolactin and Secondary Hypogonadism in Active Men

For men on testosterone replacement therapy (TRT) or those undergoing hypogonadism evaluation, prolactin is a second-tier but important lab.

How Elevated Prolactin Suppresses Testosterone

Sustained prolactin above roughly 25 ng/mL decreases GnRH pulse frequency. LH falls. Testicular Leydig cells receive less stimulation and produce less testosterone. The man presents with fatigue, low libido, and low serum testosterone, which looks clinically identical to primary or garden-variety secondary hypogonadism. Missing hyperprolactinemia in this context means the TRT addresses the symptom while leaving the cause, possibly a prolactinoma, undiagnosed and growing.

The Endocrine Society guideline recommends measuring prolactin in all men presenting with hypogonadotropic hypogonadism before initiating testosterone therapy [2].

TRT, Estradiol, and Prolactin

Exogenous testosterone aromatizes to estradiol. Estradiol is a direct stimulator of lactotroph proliferation. Men on TRT with poorly controlled estradiol (above 40 to 50 pg/mL) may see modest prolactin rises as a downstream effect. This is rarely enough to cause pathologic hyperprolactinemia on its own, but it complicates interpretation when prolactin sits in the 20 to 30 ng/mL range. Check estradiol alongside prolactin before attributing elevation to adenoma or overtraining.

Cabergoline in Clinical Practice

When prolactin is confirmed elevated on two separate draws and imaging reveals a microprolactinoma (less than 10 mm) or macroprolactinoma, dopamine agonist therapy is first-line. Cabergoline 0.25 mg twice weekly, titrated up to 0.5 to 1.0 mg twice weekly as needed, normalizes prolactin in approximately 80 to 90% of prolactinoma patients and reduces tumor size in the majority [2]. Bromocriptine is an alternative but carries more side effects and twice-daily dosing.

Optimal Prolactin Range for Active Adults and Longevity Medicine

Standard laboratory reference intervals tell you what is statistically common in a mixed population. Longevity medicine and performance medicine ask a different question: what prolactin range is associated with the best hormonal milieu, fertility markers, and long-term reproductive aging outcomes?

What the Evidence Suggests for Men

Available data from fertility and endocrine literature point to an optimal resting prolactin range of 4 to 15 ng/mL for men. Values below 4 ng/mL are rare and may indicate pituitary insufficiency (though isolated low prolactin is not a clinical entity recognized by major guidelines). Values above 15 ng/mL warrant investigation of etiology before they are dismissed as normal.

A 2020 cohort study in Andrology (N=1,214 men presenting for infertility evaluation) found that men with prolactin above 15 ng/mL had significantly lower total testosterone (mean 312 ng/dL vs. 487 ng/dL in the normal-prolactin group, P<0.001) even when prolactin remained below the conventional 18 ng/mL upper limit of normal [8]. This suggests the clinical threshold may be set too high for men whose primary concern is reproductive or hormonal optimization.

What the Evidence Suggests for Women

For non-pregnant, non-lactating women, optimal prolactin likely sits between 5 and 20 ng/mL. Women with prolactin consistently above 20 ng/mL show increased rates of luteal phase defects and cycle irregularity even without formal hyperprolactinemia diagnosis. Below 5 ng/mL, no clear adverse effect has been established in published literature.

The American Society for Reproductive Medicine (ASRM) practice committee opinion on hyperprolactinemia and reproduction notes that even mildly elevated prolactin in the 20 to 40 ng/mL range can impair ovulation and recommends treatment consideration when conception is desired [9].

Timing Prolactin Draws for Accurate Interpretation

Three variables confound a single prolactin measurement: pulsatile secretion (prolactin pulses every 90 to 120 minutes, with peaks during sleep), post-exercise elevation, and "macroprolactin" (a biologically inactive immunoglobulin-bound form that cross-reacts with standard assays). A proper protocol for active patients includes:

1. Fasting draw, morning (between 08:00 and 10:00).
2. At least 90 minutes after waking (to clear the overnight nocturnal peak).
3. At least 90 minutes after any exercise.
4. Confirm elevation on a second draw before imaging.
5. Request macroprolactin fractionation (polyethylene glycol precipitation) when prolactin sits between 25 and 100 ng/mL and symptoms are absent or mild.

Differentiating Exercise-Induced Elevation from Pathology

The clinical challenge is not recognizing severe hyperprolactinemia (a prolactin of 250 ng/mL with amenorrhea is rarely attributed to a morning jog). The challenge is the gray zone of 20 to 60 ng/mL in an athlete who trains hard.

A Practical Decision Framework

Use this four-step approach before ordering pituitary MRI:

Step 1. Confirm the draw was properly timed. Repeat the lab with the protocol above. A meaningful percentage of "elevated" results normalize on a properly timed repeat draw.

Step 2. Rule out pharmacologic causes. Antipsychotics, metoclopramide, domperidone, SSRIs, opioids, H2 blockers, and verapamil all raise prolactin via D2 antagonism or other mechanisms. Review the medication list before attributing elevation to physiology.

Step 3. Check macroprolactin. If macroprolactin accounts for more than 60% of the total immunoreactive prolactin, bioactive prolactin is likely normal, and the elevation is a laboratory artifact rather than a clinical finding.

Step 4. Assess training load and recovery status. High training volume (greater than 12 hours per week of vigorous effort) combined with poor sleep, caloric restriction, or recent competition significantly raises the pre-test probability that elevation reflects hypothalamic stress rather than a structural lesion.

MRI is warranted when prolactin exceeds 100 ng/mL on a confirmed, properly timed draw with no pharmacologic explanation, or when clinical features (visual field changes, headache, galactorrhea) are present at any level.

Prolactin and Immune Function in Athletes

One dimension of prolactin that rarely appears in hormone panels but matters for understanding the complete physiology is its role in immune regulation. Prolactin receptors are expressed on T lymphocytes, B lymphocytes, and natural killer cells. At physiologic levels, prolactin appears to support lymphocyte proliferation and survival.

The transient post-exercise prolactin spike may be part of the exercise-induced immune activation response, a brief period of enhanced immune surveillance that follows vigorous effort. A 2019 study in Exercise Immunology Review noted that the post-exercise prolactin surge correlates temporally with the acute increase in NK cell activity, though whether prolactin drives this or merely co-occurs with it remains unresolved [10].

For practical purposes, this means the post-exercise prolactin spike is not simply a noise signal. It may serve a short-term adaptive function. Suppressing it pharmacologically in healthy athletes without clinical hyperprolactinemia is not supported by evidence and is not recommended by any major guideline.

When to Treat: Thresholds and Targets

Treatment is indicated when prolactin is consistently elevated above the reference range, is causing symptoms (hypogonadism, infertility, galactorrhea, bone loss), or is associated with a pituitary tumor. Asymptomatic mild elevations (25 to 50 ng/mL) in heavily training athletes with normal menstrual cycles or normal testosterone generally warrant monitoring rather than immediate pharmacologic intervention.

Cabergoline Dosing and Monitoring

Standard starting dose: cabergoline 0.25 mg orally twice weekly. Titrate by 0.25 mg increments at 4-week intervals based on serum prolactin response. Most microprolactinoma patients achieve normal prolactin at 0.5 to 1.0 mg twice weekly. Repeat prolactin 4 weeks after each dose change. Once stable for 2 years with normal prolactin, a trial of dose reduction or discontinuation is reasonable, with MRI surveillance to confirm tumor stability [2].

The Endocrine Society guideline states: "We recommend dopamine agonist therapy rather than surgery as the initial treatment for virtually all patients with prolactinomas." [2]

Echocardiographic monitoring is recommended for patients on cumulative cabergoline doses above 2 mg per week for extended periods, given the association between high-dose dopamine agonists and cardiac valve abnormalities observed in Parkinson's disease patients (though prolactinoma doses are substantially lower than Parkinson's doses).

Monitoring Prolactin on Hormone Therapy Protocols

For patients on TRT, GH peptides, or other hormone therapy, baseline prolactin should be established before starting therapy and rechecked at 3 months and annually thereafter. Estradiol management is the primary lever for controlling TRT-related prolactin elevation. Keeping estradiol below 40 pg/mL generally keeps prolactin within acceptable bounds in this context.

GH secretagogues (ipamorelin, CJC-1295, tesamorelin) do not directly raise prolactin but increase IGF-1 and GH, which may modestly affect the HPG axis. Current evidence does not show a clinically meaningful prolactin effect from these peptides at standard doses, though data are limited and monitoring remains prudent.